| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65219-080-05 | 65219-080 | HUMAN PRESCRIPTION DRUG | Gadoterate Meglumine | gadoterate meglumine | INJECTION | INTRAVENOUS | 20220620 | N/A | ANDA | ANDA215304 | Fresenius Kabi USA, LLC | GADOTERATE MEGLUMINE | 376.9 mg/mL | 10 CARTON in 1 BOX (65219-080-05) / 1 VIAL in 1 CARTON (65219-080-01) / 5 mL in 1 VIAL |
| 65219-082-10 | 65219-082 | HUMAN PRESCRIPTION DRUG | Gadoterate Meglumine | gadoterate meglumine | INJECTION | INTRAVENOUS | 20220620 | N/A | ANDA | ANDA215304 | Fresenius Kabi USA, LLC | GADOTERATE MEGLUMINE | 376.9 mg/mL | 10 CARTON in 1 BOX (65219-082-10) / 1 VIAL in 1 CARTON (65219-082-01) / 10 mL in 1 VIAL |
| 65219-084-15 | 65219-084 | HUMAN PRESCRIPTION DRUG | Gadoterate Meglumine | gadoterate meglumine | INJECTION | INTRAVENOUS | 20220620 | N/A | ANDA | ANDA215304 | Fresenius Kabi USA, LLC | GADOTERATE MEGLUMINE | 376.9 mg/mL | 10 CARTON in 1 BOX (65219-084-15) / 1 VIAL in 1 CARTON (65219-084-01) / 15 mL in 1 VIAL |
| 65219-086-20 | 65219-086 | HUMAN PRESCRIPTION DRUG | Gadoterate Meglumine | gadoterate meglumine | INJECTION | INTRAVENOUS | 20220620 | N/A | ANDA | ANDA215304 | Fresenius Kabi USA, LLC | GADOTERATE MEGLUMINE | 376.9 mg/mL | 10 CARTON in 1 BOX (65219-086-20) / 1 VIAL in 1 CARTON (65219-086-01) / 20 mL in 1 VIAL |
| 65219-088-50 | 65219-088 | HUMAN PRESCRIPTION DRUG | Gadoterate Meglumine | gadoterate meglumine | INJECTION | INTRAVENOUS | 20220620 | N/A | ANDA | ANDA215304 | Fresenius Kabi USA, LLC | GADOTERATE MEGLUMINE | 376.9 mg/mL | 6 CARTON in 1 BOX (65219-088-50) / 1 VIAL in 1 CARTON (65219-088-06) / 100 mL in 1 VIAL |